News|Articles|March 7, 2014

Beckman Coulter Announces Partnership with Wyatt Technology

Beckman Coulter partners with Wyatt Technology to develop and market products for nanoparticle characterization.

Beckman Coulter Life Sciences announced an agreement with Wyatt Technology for collaboration on products, applications, and technical development for nanoparticle characterization. As part of the agreement, the developed products will be marketed under the Beckman Coulter Life Sciences brand.

Source: Beckman Coulter Life Sciences

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Beckman Coulter Announces Partnership with Wyatt Technology

Related Content

A Capsule-in-Capsule Platform for Multi-Phase Release of Liquid and Solid Formulations

Q&A: Sterile Injectable Manufacturers Gain New CDMO Option as Halo Expands

CPHI Milan Puts Sustainability to Work, Part 2

PharmTech Weekly Roundup—August 14, 2026

What Does TAUKLARIFY's Approval Mean for Alzheimer's Drug Developers?

Trending on Pharmaceutical Technology

A Capsule-in-Capsule Platform for Multi-Phase Release of Liquid and Solid Formulations

Europe Tried to Ban Generative AI From Critical GMP. The Ban May Not Survive. It Does Not Matter.

Q&A: Why Is Halo Pharma Expanding Into Sterile Injectables Now?

What Does TAUKLARIFY's Approval Mean for Alzheimer's Drug Developers?

Q&A: Sterile Injectable Manufacturers Gain New CDMO Option as Halo Expands